[1. Burke W, Atkins D, Gwinn M, et al. Genetic test evaluation: information needs of clinicians, policy makers, and the public. Am J Epidemiol. 2002;156:311-318.10.1093/aje/kwf05512181100]Search in Google Scholar
[2. Holtzman NA, Watson MS. Promoting safe and effective genetic testing in the United States. Final report of the Task Force on Genetic Testing. J Child Fam Nurs. 1999 Sep-Oct; 2(5):388-90.10.1093/clinchem/45.5.732]Search in Google Scholar
[3. Khoury MJ, Jones K, Grosse SD. Quantifying the health benefits of genetic tests: the importance of a population perspective. Genet Med 2006;8:191-195.10.1097/01.gim.0000206278.37405.2516540755]Search in Google Scholar
[4. Javaher P, Kaariainen H, Kristoffersson U, Nippert I, Sequeiros J, Zimmern R, Schmidtke J. EuroGentest: DNA-based testing for heritable disorders in Europe. Community Genet. 2008;11(2):75-120. 10.1159/00011198418204250]Search in Google Scholar
[5. Newman NJ, Biousse V. Hereditary optic neuropathies. Eye 2004;18:1144-6010.1038/sj.eye.670159115534600]Open DOISearch in Google Scholar
[6. Kondo H, Qin M, Tahira T, Uchio E, Hayashi K. Severe form of familial exudative vitreoretinopathy caused by homozygous R417Q mutation in frizzled-4 gene. Ophthalmic Genet 2007;28: 220-3.10.1080/1381681070166354318161623]Open DOISearch in Google Scholar
[7. Robitaille JM, Wallace K, Zheng B, et al. Phenotypic overlap of familial exudative vitreoretinopathy (FEVR) with persistent fetal vasculature (PFV) caused by FZD4 mutations in two distinct pedigrees. Ophthalmic Genet 2009;30:23-30.10.1080/1381681080246431219172507]Open DOISearch in Google Scholar
[8. Chung DC, Traboulsi EI. Leber congenital amaurosis: Clinical correlations with genotypes, gene therapy trials update, and future directions. J AAPOS 2009;13:587-92.10.1016/j.jaapos.2009.10.00420006823]Search in Google Scholar
[9. Corson TW and Gallie BL. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosomes Cancer 46:617-63410.1002/gcc.2045717437278]Search in Google Scholar
[10. Sharif W and Sharif Z. Leber’s congenital amaurosis and the role of gene therapy in congenital retinal disorders Int J Ophthalmol. 2017; 10(3): 480-484.]Search in Google Scholar
[11. Maclachlan TK, Lukason M, Collins M, Munger R, Isenberger E, Rogers C, Malatos S, Dufresne E, Morris J, Calcedo R, Veres G, Scaria A, Andrews L, Wadsworth S. Preclinical safety evaluation of AAV2-sFLT01- a gene therapy for age-related macular degeneration. Mol Ther. 2011;19(2):326-334.10.1038/mt.2010.258303485221119620]Search in Google Scholar
[12. Stone EM, Aldave AJ, Drack AV et al. Recommendations for genetic testing of inherited eye diseases: report of the American Academy of Ophthalmology task force on genetic testing. Ophthalmology 2012: 119 (11): 2408-2410.10.1016/j.ophtha.2012.05.04722944025]Search in Google Scholar
[13. Borry P and Howard HC. Personal genome testing: do you know what you are buying? Am J Bioeth. 2009;9(6-7):11-3.10.1080/1526516090289400519998102]Search in Google Scholar
[14. Parke DW The American Academy of Ophthalmology and the Formation of the American Board of Ophthalmology. Ophthalmology. 2016 Sep;123(9 Suppl):S12-4.10.1016/j.ophtha.2016.06.00927549995]Search in Google Scholar
[15. Morad Y, Sutherland J, DaSilva L, et al. The Ocular Genetics Program: multidisciplinary care of patients with ocular genetic eye disease. Can J Ophthalmol 2007; 42:734-738.10.3129/i07-14417891201]Open DOISearch in Google Scholar
[16. Gabriel LAR and Traboulsi EI. Genetic Diagnostic Methods for Inherited Eye Diseases. Middle East Afr J Ophthalmol. 2011; 18(1): 24-29.10.4103/0974-9233.75881308514821572730]Search in Google Scholar
[17. Xuan J, Yu Y, Qing T, Guo L, Shi L. Next-generation sequencing in the clinic: promises and challenges. Cancer Lett 2013; 340: 284-295.10.1016/j.canlet.2012.11.025573931123174106]Search in Google Scholar
[18. Grody WW, Thompson BH, Gregg AR, Bean LH, Monaghan KG, Schneider A, Lebo RV. ACMG position statement on prenatal/ preconception expanded carrier screening. Genet Med. 2013; 15(6):482-48310.1038/gim.2013.4723619275]Open DOISearch in Google Scholar
[19. Consugar MB, Navarro-Gomez D, Place E, Bujakowska KM, Sousa ME, Fonseca-Kelly ZD, Taub DG, Janessian M, Wang DY, Au ED, Sims KB, Sweetser DA, Fulton AB, Liu Q, Wiggs JL, Gai X, Pierce EA. Panel-based genetic diagnostic testing for inherited eye diseases is highly accurate and reproducible and more sensitive for variant detection than exome sequencing. Genet Med. 2015; 17(4): 253-261.10.1038/gim.2014.172457257225412400]Search in Google Scholar
[20. Gillespie RL, O’Sullivan J, Ashworth J et al: Personalized diagnosis and management of congenital cataract by next-generation sequencing. Ophthalmology 2014; 121: 2124-2137 e2121-2122.10.1016/j.ophtha.2014.06.00625148791]Search in Google Scholar
[21. Sullivan LS, Bowne SJ, Seaman CR, et al. Genomic rearrangements of the PRPF31 gene account for 2.5% of autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci 2006;47:4579-4588.10.1167/iovs.06-0440277820517003455]Search in Google Scholar
[22. Anasagasti A, Irigoyen C, Barandika O, López de Munain A, Ruiz-Ederra J. Current mutation discovery approaches in Retinitis Pigmentosa. Vision Res 2012;75:117-129.10.1016/j.visres.2012.09.01223022136]Search in Google Scholar
[23. Lee H, Deignan JL, Dorrani N, et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA 2014;312:1880-1887.10.1001/jama.2014.14604427863625326637]Search in Google Scholar
[24. O’Sullivan J, Mullaney BG, Bhaskar SS et al. A paradigm shift in the delivery of services for diagnosis of inherited retinal disease. J Med Genet 2012: 49: 322-326.10.1136/jmedgenet-2012-10084722581970]Search in Google Scholar
[25. Harvey A, Brand A, Holgate ST et al. The future of technologies for personalised medicine. N Biotechnol 2012: 29: 625-633.10.1016/j.nbt.2012.03.00923091837]Search in Google Scholar
[26. Chair SR, Aziz N, Bale S, Bick D, Das S, Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5): 405-424.10.1038/gim.2015.30454475325741868]Search in Google Scholar
[27. Fan BJ, Wiggs JL. Glaucoma: genes, phenotypes, and new directions for therapy. Journal Clinical Investigation. 2010;120:3064-72.10.1172/JCI43085292973320811162]Search in Google Scholar
[28. Wiggs JL, Howell GR, Linkroum K, Abdrabou W, Hodges E, Braine CE, Pasquale LR, Hannon GJ, Haines JL, John SWM. Variations in COL15A1 and COL18A1 influence age of onset of primary open angle glaucoma. Clin Genet. 2013; 84(2):167-74.10.1111/cge.12176377139423621901]Open DOISearch in Google Scholar
[29. Boye SE, Boye SL, Lewin AS, Hauswirth WW. A comprehensive review of retinal gene therapy. Mol Ther 2013: 21 (3): 509-519.10.1038/mt.2012.280364228823358189]Open DOISearch in Google Scholar
[30. Blain D, Goetz KE, Ayyagari R, Tumminiac SJ. eyeGENE®: a vision community resource facilitating patient care and paving the path for research through molecular diagnostic testing. Clin Genet. 2013 Aug; 84(2): 10.1111/cge.12193.10.1111/cge.12193381639823662816]Search in Google Scholar